These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22932438)

  • 1. Clinical approval: Trials of an anticancer jab.
    Clayton J
    Nature; 2012 Aug; 488(7413):S4-6. PubMed ID: 22932438
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccination: A durable design.
    Sanderson K
    Nature; 2012 Aug; 488(7413):S7. PubMed ID: 22932439
    [No Abstract]   [Full Text] [Related]  

  • 3. HPV vaccination and cervical cancer.
    Szarewski A
    Curr Oncol Rep; 2012 Dec; 14(6):559-67. PubMed ID: 22890794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
    Goldstone SE; Vuocolo S
    Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the new HPV vaccines in clinical practice.
    Widdice LE; Kahn JA
    Cleve Clin J Med; 2006 Oct; 73(10):929-35. PubMed ID: 17044318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV vaccines: what remains to be done? Interview by Lauren Constable.
    Zur Hausen H
    Expert Rev Vaccines; 2011 Nov; 10(11):1505-7. PubMed ID: 22043949
    [No Abstract]   [Full Text] [Related]  

  • 7. HPV vaccination in Southern Africa: A jab of hope in the fight against cervical cancer.
    Michelow P; Firnhaber C
    Cancer Cytopathol; 2016 Oct; 124(10):695-698. PubMed ID: 27182785
    [No Abstract]   [Full Text] [Related]  

  • 8. Epidemiology and prevention of Human Papillomavirus.
    Manini I; Montomoli E
    Ann Ig; 2018; 30(4 Supple 1):28-32. PubMed ID: 30062377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV and cervical cancer in the 2007 report.
    WHO/ICO Information Centre on HPV and Cervical Cancer
    Vaccine; 2007 Nov; 25 Suppl 3():C1-230. PubMed ID: 18068032
    [No Abstract]   [Full Text] [Related]  

  • 10. Human papillomavirus-associated diseases in Israel--the controversy continues. Foreword.
    Bornstein J; Shavit O
    Vaccine; 2013 Nov; 31 Suppl 8():vii-x. PubMed ID: 24229722
    [No Abstract]   [Full Text] [Related]  

  • 11. Who should be vaccinated against human papillomavirus?
    Tjalma WA; van Damme P
    Int J Gynecol Cancer; 2006; 16(4):1498-9. PubMed ID: 16884357
    [No Abstract]   [Full Text] [Related]  

  • 12. Investigational 9-valent HPV vaccine could prevent almost 90% of cervical cancers.
    Hum Vaccin Immunother; 2014; 10(11):3105-6. PubMed ID: 25789368
    [No Abstract]   [Full Text] [Related]  

  • 13. Australian HPV vaccination programme yields results.
    Howe M
    Lancet Oncol; 2014 Dec; 15(13):e591. PubMed ID: 25499291
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recommendations for the definition of a policy on vaccination against papillomavirus in Mexico. Strategic Advisory Group of Experts of the World Health Organization].
    Lazcano-Ponce E; Salmerón-Castro J; García-Carrancá A; Aranda-Flores C; Madrid-Marina V; Gómez-Altamirano CM; Martínez-Montañez OG
    Salud Publica Mex; 2009; 51(4):336-41. PubMed ID: 19668929
    [No Abstract]   [Full Text] [Related]  

  • 15. HPV vaccination: the beginning of the end of cervical cancer? - A Review.
    Lepique AP; Rabachini T; Villa LL
    Mem Inst Oswaldo Cruz; 2009 Feb; 104(1):1-10. PubMed ID: 19274369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticipating full benefits from the new papillomavirus vaccines.
    Griffiths PD
    Rev Med Virol; 2007; 17(1):1-3. PubMed ID: 17173349
    [No Abstract]   [Full Text] [Related]  

  • 17. HPV vaccination to prevent HIV infection: time for randomized controlled trials.
    van der Loeff MF; Nyitray AG; Giuliano AR
    Sex Transm Dis; 2011 Jul; 38(7):640-3. PubMed ID: 21301387
    [No Abstract]   [Full Text] [Related]  

  • 18. Developments in L2-based human papillomavirus (HPV) vaccines.
    Schellenbacher C; Roden RBS; Kirnbauer R
    Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV, vaccines, and cervical cancer in a low- and middle-income country.
    Petersen LM; Fenton JM; Kennedy LS; LaRochelle EPM; Bejarano S; Tsongalis GJ
    Curr Probl Cancer; 2020 Dec; 44(6):100605. PubMed ID: 32507365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [PAPILLOMAVIRUS INFECTION: PRINCIPLE CHARACTERISTICS, CLINICAL MANIFESTATIONS, VACCINE PROPHYLAXIS].
    Lopukhov PD; Briko NI; Khaldin AA; Tsapkova NN; Lupashko OV
    Zh Mikrobiol Epidemiol Immunobiol; 2016; (1):71-8. PubMed ID: 27029121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.